From the Breakthroughs Blog: Page #2

Research Roundup: Caution on hydroxychloroquine, BARDA director ousted, first at-home COVID-19 test

PATH/ Patrick McKern

April 26, 2020

Research Roundup: Caution on hydroxychloroquine, BARDA director ousted, first at-home COVID-19 test

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Julien Rashid GHTC

Read more

Research Roundup: Early data suggests COVID-19 patients are responding to remdesivir, Sanofi & GSK partner to develop coronavirus vaccine, and US halts payments to WHO

PATH/Gabe Bienczycki

April 19, 2020

Research Roundup: Early data suggests COVID-19 patients are responding to remdesivir, Sanofi & GSK partner to develop coronavirus vaccine, and US halts payments to WHO

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Ansley Kahn

GHTC

Read More

Research Roundup: NIH starts hydroxychloroquine clinical trial, clinical trial begins of second US COVID-19 vaccine, and anti-parasite drug may help treat coronavirus

April 12, 2020

Research Roundup: NIH starts hydroxychloroquine clinical trial, clinical trial begins of second US COVID-19 vaccine, and anti-parasite drug may help treat coronavirus

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Ansley Kahn

GHTC

Read More

Research Roundup: Study finds malaria drug helps improve COVID-19 patients, J&J and Moderna sign deals with US to produce coronavirus vaccines, and FDA authorizes 15-minute coronavirus test

PATH/Patrick McKern

April 5, 2020

Research Roundup: Study finds malaria drug helps improve COVID-19 patients, J&J and Moderna sign deals with US to produce coronavirus vaccines, and FDA authorizes 15-minute coronavirus test

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Ansley Kahn

GHTC

Read More

Research Roundup: Coronavirus not mutating quickly, FDA authorizes plasma treatment for COVID-19, and new COVID-19 rapid diagnostic

PATH/Patrick McKern

March 30, 2020

Research Roundup: Coronavirus not mutating quickly, FDA authorizes plasma treatment for COVID-19, and new COVID-19 rapid diagnostic

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Ansley Kahn

GHTC

Read More

Research Roundup: Access to experimental COVID-19 drug paused, WHO to launch coronavirus drug trial, and Takeda's dengue vaccine shows promise in clinical trials

PATH/Gabe Bienczycki

March 22, 2020

Research Roundup: Access to experimental COVID-19 drug paused, WHO to launch coronavirus drug trial, and Takeda's dengue vaccine shows promise in clinical trials

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Ansley Kahn

GHTC

Read More